Ethinylestradiol + Gestodene is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Prevention of Pregnancy

• The dosage of Ethinylestradiol + Gestodene should be individualized based on the patient's medical history and response to therapy. The usual dosage is one tablet taken by mouth daily at the same time each day for 21 consecutive days. The tablets should be taken in the order directed on the package and at the same time every day, preferably after the evening meal or at bedtime.
• A backup method of contraception should be used during the first 7 days of the first cycle of use.

The most common adverse reactions associated with Ethinylestradiol + Gestodene include nausea, vomiting, headache, acne, vaginal bleeding/ discharge, increased appetite & breast tenderness. Other less common side effects may include mood changes, fluid retention, changes in libido, and weight gain. Rare but serious adverse reactions may include blood clots, liver tumors, and hypertension.

Nausea

Headache

Breast Tenderness

Vaginal Discharge

• Women who smoke cigarettes are at an increased risk of serious cardiovascular events while taking Ethinylestradiol + Gestodene.
• The use of Ethinylestradiol + Gestodene may increase the risk of venous and arterial thromboembolic events, especially in women with a history of these events or other risk factors.
• Ethinylestradiol + Gestodene should not be used in women who are pregnant or breastfeeding.
• The risk of cervical cancer may be increased with long-term use of Ethinylestradiol + Gestodene.
• Women with a history of depression or other mental health disorders should be closely monitored while taking Ethinylestradiol + Gestodene.
• Ethinylestradiol + Gestodene should be discontinued if jaundice or other signs of liver dysfunction occur.
• Women with a history of cholestasis or other liver disorders should not use Ethinylestradiol + Gestodene.